Alma Therapeutics is a company focused on developing a disruptive capsule for the oral delivery of complex and biologic molecules. Their novel drug delivery platform is specifically designed for the oral delivery of molecules such as peptides, proteins, and antibodies. With its emphasis on Health Care, the company is gaining attention in the pharmaceutical industry. Despite the lack of specific founding and headquarter information, Alma Therapeutics presents an intriguing investment opportunity in the field of biologics delivery. As of now, there is no publicly available data regarding the last investment and its investors, which leaves room for further observation.
There is no investment information
No recent news or press coverage available for Alma Therapeutics - Next Generation Oral Biologics Delivery.